Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Nov 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of tobacco-free nicotine pouches, which are a less harmful option compared to traditional cigarettes, in helping smokers quit. The researchers want to find out if using these pouches with different levels of nicotine can support people in switching away from smoking. If you're a current smoker, over the age of 21, and have been smoking regularly for at least a year, you might be eligible to participate. You should not have used nicotine pouches more than five times in your life and must be willing to attend two visits in Charleston for testing.
If you join the study, you'll answer questions about your smoking habits and provide some samples at the first visit. Then, you'll receive a 28-day supply of nicotine pouches to use as you try to stop smoking. After four weeks, you'll return for a final visit and answer more questions about your experience. It's important to note that you should not be using other tobacco products or smoking cessation medications during the trial. This study is an opportunity to explore a new way to quit smoking while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 21+
- • current cigarette smoking (25+ days per previous month, 5 or more cigarettes/day, for greater than 1yr, greater than 100 lifetime cigarettes)
- • have not used TNFPs more than 5 times during their lifetime
- • willing and able to attend 2 in-person visits in Charleston (to assess biomarkers)
- • have internet access
- Exclusion Criteria:
- • Lack of proficiency in English.
- • Use of other combustible tobacco products (i.e., cigars, cigarillos, hookahs) and/or other non-combusted nicotine/tobacco products (i.e., e-cigarettes, smokeless tobacco) in the past 30 days.
- • Current use of smoking cessation medications (i.e., varenicline, bupropion, nicotine replacement therapy).
- • Use of marijuana within the past month, and unwillingness to abstain from marijuana during course of study.
- • Medical conditions contraindicated to NRT use (including pregnancy, breastfeeding, and nursing, past month myocardial infarction, current untreated cardiac arrhythmia, current severe angina, current uncontrolled severe vascular disease).
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Charleston, South Carolina, United States
Patients applied
Trial Officials
Amanda Palmer, PhD.
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported